Clinical Use of Quantitative Computed Tomography (QCT) of the Hip in the Management of Osteoporosis in Adults: the 2015 ISCD Official Positions-Part I.

The International Society for Clinical Densitometry (ISCD) has developed new official positions for the clinical use of quantitative computed tomography of the hip. The ISCD task force for quantitative computed tomography reviewed the evidence for clinical applications and presented a report with recommendations at the 2015 ISCD Position Development Conference. Here, we discuss the agreed on ISCD official positions with supporting medical evidence, rationale, controversy, and suggestions for further study. Parts II and III address the advanced techniques of finite element analysis applied to computed tomography scans and the clinical feasibility of existing techniques for opportunistic screening of osteoporosis using computed tomography scans obtained for other diagnosis such as colonography was addressed.

[1]  R. Eastell,et al.  Site-specific differential effects of once-yearly zoledronic acid on the hip assessed with quantitative computed tomography: results from the HORIZON Pivotal Fracture Trial , 2012, Osteoporosis International.

[2]  M S Calvo,et al.  Prevalence of Low Femoral Bone Density in Older U.S. Adults from NHANES III , 1997, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[3]  P. Pickhardt,et al.  Comparison of femoral neck BMD evaluation obtained using Lunar DXA and QCT with asynchronous calibration from CT colonography. , 2015, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[4]  J. Fletcher,et al.  Validation of a CT-Derived Method for Osteoporosis Screening in IBD Patients Undergoing Contrast-Enhanced CT Enterography , 2014, The American Journal of Gastroenterology.

[5]  Ying Lu,et al.  Proximal femoral density and geometry measurements by quantitative computed tomography: association with hip fracture. , 2007, Bone.

[6]  Lang Yang,et al.  Distribution of bone density in the proximal femur and its association with hip fracture risk in older men: The osteoporotic fractures in men (MrOS) study , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[7]  S. Cummings,et al.  Clinical use of bone densitometry: scientific review. , 2002, JAMA.

[8]  L. Palermo,et al.  One year of alendronate after one year of parathyroid hormone (1-84) for osteoporosis. , 2005, The New England journal of medicine.

[9]  T. Therneau,et al.  Association of hip strength estimates by finite‐element analysis with fractures in women and men , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[10]  Y. Lu,et al.  Quality and performance measures in bone densitometry , 2006, Osteoporosis International.

[11]  R. Lindsay,et al.  Effect of Recombinant Human Parathyroid Hormone (1-84) on Vertebral Fracture and Bone Mineral Density in Postmenopausal Women with Osteoporosis , 2007, Annals of Internal Medicine.

[12]  H. Genant,et al.  Ronacaleret, a calcium‐sensing receptor antagonist, increases trabecular but not cortical bone in postmenopausal women , 2012, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[13]  Mary L Bouxsein,et al.  The effects of parathyroid hormone and alendronate alone or in combination in postmenopausal osteoporosis. , 2003, The New England journal of medicine.

[14]  Tamara B Harris,et al.  Similarities and differences between sexes in regional loss of cortical and trabecular bone in the mid‐femoral neck: The AGES‐Reykjavik longitudinal study , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[15]  H. Genant,et al.  Odanacatib Treatment Affects Trabecular and Cortical Bone in the Femur of Postmenopausal Women: Results of a Two‐Year Placebo‐Controlled Trial , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[16]  M. Ito,et al.  Classification of women with and without hip fracture based on quantitative computed tomography and finite element analysis , 2014, Osteoporosis International.

[17]  C. Cann,et al.  CTXA Hip—An Extension of Classical DXA Measurements Using Quantitative CT , 2014, PloS one.

[18]  S. Cummings,et al.  Randomised trial of effect of alendronate on risk of fracture in women with existing vertebral fractures , 1996, The Lancet.

[19]  Andrew H Gee,et al.  Denosumab Rapidly Increases Cortical Bone in Key Locations of the Femur: A 3D Bone Mapping Study in Women With Osteoporosis , 2015, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[20]  H. Genant,et al.  Once-monthly oral ibandronate improves biomechanical determinants of bone strength in women with postmenopausal osteoporosis. , 2009, The Journal of clinical endocrinology and metabolism.

[21]  Yong-bin Su,et al.  Validation of quantitative computed tomography‐derived areal bone mineral density with dual energy X‐ray absorptiometry in an elderly Chinese population , 2014, Chinese medical journal.

[22]  D. Cody,et al.  Femoral structure and stiffness in patients with femoral neck fracture , 2000, Journal of orthopaedic research : official publication of the Orthopaedic Research Society.

[23]  Mary L Bouxsein,et al.  Proximal Femoral Structure and the Prediction of Hip Fracture in Men: A Large Prospective Study Using QCT , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[24]  Klaus Engelke,et al.  In vivo discrimination of hip fracture with quantitative computed tomography: Results from the prospective European Femur Fracture Study (EFFECT) , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[25]  C. Cann,et al.  Comparison of QCT-derived and DXA-derived areal bone mineral density and T scores , 2009, Osteoporosis International.

[26]  W. Skalli,et al.  Volumetric quantitative computed tomography of the proximal femur: relationships linking geometric and densitometric variables to bone strength. Role for compact bone , 2006, Osteoporosis International.

[27]  J. Shepherd,et al.  A generalized least significant change for individuals measured on different DXA systems. , 2007, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[28]  Jacques P. Brown,et al.  Denosumab densitometric changes assessed by quantitative computed tomography at the spine and hip in postmenopausal women with osteoporosis. , 2013, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[29]  C. Graeff,et al.  Quantitative computed tomographic assessment of the effects of 24 months of teriparatide treatment on 3D femoral neck bone distribution, geometry, and bone strength: Results from the EUROFORS study , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[30]  W. Schima,et al.  Overlapping and Continued Alendronate or Raloxifene Administration in Patients on Teriparatide: Effects on Areal and Volumetric Bone Mineral Density—The CONFORS Study , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[31]  V. Gudnason,et al.  Assessment of incident spine and hip fractures in women and men using finite element analysis of CT scans , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[32]  H. Genant,et al.  The Effect of the Cathepsin K Inhibitor ONO‐5334 on Trabecular and Cortical Bone in Postmenopausal Osteoporosis: The OCEAN Study , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[33]  B. Zemel,et al.  Quantitative computer tomography in children and adolescents: the 2013 ISCD Pediatric Official Positions. , 2014, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[34]  Dennis M Black,et al.  Femoral Bone Strength and Its Relation to Cortical and Trabecular Changes After Treatment With PTH, Alendronate, and Their Combination as Assessed by Finite Element Analysis of Quantitative CT Scans , 2008, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[35]  H. Resch,et al.  Antiresorptives overlapping ongoing teriparatide treatment result in additional increases in bone mineral density , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[36]  K. Engelke.  Assessment of bone quality and strength with new technologies , 2012, Current opinion in endocrinology, diabetes, and obesity.

[37]  Atsushi Harada,et al.  Analysis of hip geometry by clinical CT for the assessment of hip fracture risk in elderly Japanese women. , 2010, Bone.

[38]  Mathieu Charlebois,et al.  Improvements in Vertebral Body Strength Under Teriparatide Treatment Assessed In Vivo by Finite Element Analysis: Results From the EUROFORS Study , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[39]  H K Genant,et al.  Measurement of bone mineral density at the spine and proximal femur by volumetric quantitative computed tomography and dual-energy X-ray absorptiometry in elderly women with and without vertebral fractures. , 2002, Bone.

[40]  Christian Graeff,et al.  Monitoring Teriparatide‐Associated Changes in Vertebral Microstructure by High‐Resolution CT In Vivo: Results From the EUROFORS Study , 2007, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[41]  Shreyasee Amin,et al.  Age-Dependence of Femoral Strength in White Women and Men , 2009, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[42]  Mary L Bouxsein,et al.  Mechanical Contributions of the Cortical and Trabecular Compartments Contribute to Differences in Age-Related Changes in Vertebral Body Strength in Men and Women Assessed by QCT-Based Finite Element Analysis , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[43]  V. Torri,et al.  Effect of spinal degenerative changes on volumetric bone mineral density of the central skeleton as measured by quantitative computed tomography , 2005, Acta radiologica.

[44]  B. Riggs,et al.  Three-dimensional structural analysis of the proximal femur in an age-stratified sample of women. , 2013, Bone.

[45]  D. Bauer,et al.  Short-term changes in bone turnover markers and bone mineral density response to parathyroid hormone in postmenopausal women with osteoporosis. , 2006, The Journal of clinical endocrinology and metabolism.

[46]  T. Keaveny,et al.  Hip and spine strength effects of adding versus switching to teriparatide in postmenopausal women with osteoporosis treated with prior alendronate or raloxifene , 2013, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[47]  H K Genant,et al.  Volumetric quantitative computed tomography of the proximal femur: precision and relation to bone strength. , 1997, Bone.

[48]  D. Kerr,et al.  The effects of a two‐year randomized, controlled trial of whey protein supplementation on bone structure, IGF‐1, and urinary calcium excretion in older postmenopausal women , 2011, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[49]  V. Gudnason,et al.  Fracture risk assessment in older adults using a combination of selected quantitative computed tomography bone measures: a subanalysis of the Age, Gene/Environment Susceptibility-Reykjavik Study. , 2014, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[50]  B. Dardzinski,et al.  Bone density, turnover, and estimated strength in postmenopausal women treated with odanacatib: a randomized trial. , 2013, The Journal of clinical endocrinology and metabolism.

[51]  S. Boonen,et al.  Early responsiveness of women with osteoporosis to teriparatide after therapy with alendronate or risedronate. , 2008, The Journal of clinical endocrinology and metabolism.

[52]  Andrew H. Gee,et al.  Imaging the femoral cortex: Thickness, density and mass from clinical CT , 2012, Medical Image Anal..

[53]  H. Genant,et al.  Regional distribution of spine and hip QCT BMD responses after one year of once-monthly ibandronate in postmenopausal osteoporosis. , 2010, Bone.

[54]  P. Lips,et al.  First line zidovudine/lamivudine/lopinavir/ritonavir leads to greater bone loss compared to nevirapine/lopinavir/ritonavir , 2009, AIDS.

[55]  V. Gudnason,et al.  Male-female differences in the association between incident hip fracture and proximal femoral strength: a finite element analysis study. , 2011, Bone.

[56]  Wenjun Li,et al.  Automated registration of hip and spine for longitudinal QCT studies: integration with 3D densitometric and structural analysis. , 2006, Bone.

[57]  Tamara B Harris,et al.  Distribution of cortical bone in the femoral neck and hip fracture: a prospective case-control analysis of 143 incident hip fractures; the AGES-REYKJAVIK Study. , 2011, Bone.

[58]  R. Eastell,et al.  Distribution of bone density and cortical thickness in the proximal femur and their association with hip fracture in postmenopausal women: a quantitative computed tomography study , 2013, Osteoporosis International.

[59]  L. Melton,et al.  Relationship of femoral neck areal bone mineral density to volumetric bone mineral density, bone size, and femoral strength in men and women , 2011, Osteoporosis International.

[60]  J. Reeve,et al.  Changing structure of the femoral neck across the adult female lifespan , 2010, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.

[61]  Joyce H. Keyak,et al.  Differences in hip quantitative computed tomography (QCT) measurements of bone mineral density and bone strength between glucocorticoid-treated and glucocorticoid-naïve postmenopausal women , 2005, Osteoporosis International.

[62]  H. Genant,et al.  Improvements in hip trabecular, subcortical, and cortical density and mass in postmenopausal women with osteoporosis treated with denosumab. , 2013, Bone.

[63]  T. Harris,et al.  Age-related loss of proximal femoral strength in elderly men and women: the Age Gene/Environment Susceptibility Study--Reykjavik. , 2012, Bone.

[64]  S. Boonen,et al.  Effect of once-yearly zoledronic acid on the spine and hip as measured by quantitative computed tomography: results of the HORIZON Pivotal Fracture Trial , 2010, Osteoporosis International.

[65]  Y. Rhee,et al.  Differences in femoral neck geometry associated with age and ethnicity , 2011, Osteoporosis International.

[66]  Gabriele Armbrecht,et al.  Clinical use of quantitative computed tomography and peripheral quantitative computed tomography in the management of osteoporosis in adults: the 2007 ISCD Official Positions. , 2008, Journal of clinical densitometry : the official journal of the International Society for Clinical Densitometry.

[67]  T. Keaveny,et al.  Effects of Teriparatide and Alendronate on Vertebral Strength as Assessed by Finite Element Modeling of QCT Scans in Women With Osteoporosis , 2006, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.